[1]
P. Koroglu Aydin and I. Bugan, “Riluzole and ranolazine application of prostate cancer: Cancer related testicular and liver tissue damage”, Exp Biomed Res, vol. 5, no. 1, pp. 10–22, Dec. 2021.